Search results
Jan 16, 2024 · About Anavex Life Sciences Corp. Anavex Life Sciences Corp. (Nasdaq: AVXL) is a publicly traded biopharmaceutical company dedicated to the development of novel therapeutics for the treatment of ...
Nov 20, 2023 · Anavex Life Sciences Corp AVXL shares are trading higher Monday. The clinical-stage biopharmaceutical company announced that it initiated a regulatory submission with the European Medicines Agency ...
The company's operating segment is into developing novel therapies for the management of CNS diseases. In depth view into AVXL (Anavex Life Sciences) stock including the latest price, news, dividend history, earnings information and financials.
3 days ago · Anavex Life Sciences (AVXL) News Today. Anavex Life Sciences Corp. (NASDAQ:AVXL - Get Free Report) Director Steffen Thomas purchased 5,000 shares of the business's stock in a transaction on Wednesday, May 15th. The stock was purchased at an average price of $4.52 per share, with a total value of $22,600.00.
Nov 27, 2023 · Shares of Anavex Life Sciences Corp. (NASDAQ: AVXL) moved lower during Monday’s session after the company reported fourth-quarter financial results.
May-14-24 10:15AM. NASDAQ: AVXL Investor Notice: Update in Lawsuit for Investors who purchased shares of Anavex Life Sciences Corp. (NASDAQ: AVXL) announced by the Shareholders Foundation. (GlobeNewswire) +8.02%. 07:30AM.
Get the latest Anavex Life Sciences Corp. (AVXL) stock price, news, buy or sell recommendation, and investing advice from Wall Street professionals.
